E-LIB Suche - Ergebnisse für: Belger, Mark

1

Testing the "RCT augmentation" methodology: A trial simulat..:

Nordon, Clementine ; Sanchez, Benoit ; Zhang, Mei...
Contemporary Clinical Trials Communications. 33 (2023) - p. 101142 , 2023

Link: https://doi.org/10.1016/..

2

Long‐term cost‐effectiveness analysis of tirzepatide versus..:

Valentine, William J. ; Hoog, Meredith ; Mody, Reema..
Diabetes, Obesity and Metabolism. 25 (2023) 5 - p. 1292-1300 , 2023

Link: https://doi.org/10.1111/..

3

Cost‐effectiveness models for Alzheimer's disease and relat..:

Handels, Ron L.H. ; Green, Colin ; Gustavsson, Anders...
Alzheimer's & Dementia. 19 (2022) 5 - p. 1800-1820 , 2022

Link: https://doi.org/10.1002/..

4

Health economic modeling for Alzheimer's disease: Expert pe..:

Landeiro, Filipa ; Morton, Jasmine ; Gustavsson, Anders...
Alzheimer's & Dementia: Translational Research & Clinical Interventions. 8 (2022) 1 - p. , 2022

Link: https://doi.org/10.1002/..

5

Comparative Effectiveness of Dexamethasone in Hospitalized ..:

Choong, Casey Kar-Chan ; Belger, Mark ; Koch, Alisa E....
Advances in Therapy. 39 (2022) 10 - p. 4723-4741 , 2022

Link: https://doi.org/10.1007/..

6

Validating the Assumptions of Population Adjustment: Applic..:

Phillippo, David M. ; Dias, Sofia ; Ades, A. E....
Medical Decision Making. 43 (2022) 1 - p. 53-67 , 2022

Link: https://doi.org/10.1177/..

7

Assessing the Cost-effectiveness of a Hypothetical Disease-..:

Boustani, Malaz ; Doty, Erin G. ; Garrison Jr, Louis P....
Clinical Therapeutics. 44 (2022) 11 - p. 1449-1462 , 2022

Link: https://doi.org/10.1016/..

8

Relative efficacy of lasmiditan versus rimegepant and ubrog..:

Polavieja, Pepa ; Belger, Mark ; Venkata, Shiva Kumar..
The Journal of Headache and Pain. 23 (2022) 1 - p. , 2022

Link: https://doi.org/10.1186/..

9

Demonstration of Clinical Meaningfulness of the Integrated ..:

Wessels, Alette M. ; Belger, Mark ; Johnston, Joseph A....
Journal of Alzheimer's Disease. 88 (2022) 2 - p. 577-588 , 2022

Link: https://doi.org/10.3233/..

10

Cost-Effectiveness of Baricitinib Compared With Standard of..:

Ohsfeldt, Robert ; Kelton, Kari ; Klein, Tim...
Clinical Therapeutics. 43 (2021) 11 - p. 1877-1893.e4 , 2021

Link: https://doi.org/10.1016/..

11

Cost-Effectiveness of Combination of Baricitinib and Remdes..:

Kelton, Kari ; Klein, Tim ; Murphy, Dan...
Advances in Therapy. 39 (2021) 1 - p. 562-582 , 2021

Link: https://doi.org/10.1007/..

12

Complementary pre‐screening strategies to uncover hidden pr..:

Boada, Mercè ; Rodrigo, Adrián ; Jessen, Frank...
Alzheimer's & Dementia. 18 (2021) 6 - p. 1119-1127 , 2021

Link: https://doi.org/10.1002/..

13

A Cost-Consequence Analysis of Different Screening Procedur..:

Wimo, Anders ; Belger, Mark ; Bon, Jaka...
Journal of Alzheimer's Disease. 83 (2021) 3 - p. 1149-1159 , 2021

Link: https://doi.org/10.3233/..

14

Health-related quality of life in people with predementia A..:

on behalf of the ROADMAP consortium ; Landeiro, Filipa ; Mughal, Seher...
Alzheimer's Research & Therapy. 12 (2020) 1 - p. , 2020

Link: https://doi.org/10.1186/..

15

Reweighting Randomized Controlled Trial Evidence to Better ..:

Happich, Michael ; Brnabic, Alan ; Faries, Douglas...
Clinical Pharmacology & Therapeutics. 108 (2020) 4 - p. 817-825 , 2020

Link: https://doi.org/10.1002/..